Literature DB >> 25735323

Impact of age, tumor size, lymph node metastasis, stage, receptor status and menopausal status on overall survival of breast cancer patients in Pakistan.

Humera Mahmood1, Mohammad Faheem, Sana Mahmood, Maryam Sadiq, Javaid Irfan.   

Abstract

BACKGROUND: Survival of breast cancer patients depends on a number of factors which are not only prognostic but are also predictive. A number of studies have been carried out worldwide to find out prognostic and predictive significance of different clinicopathological and molecular variables in breast cancer. This study was carried out at Nuclear Medicine, Oncology and Radiotherapy Institute (NORI), Islamabad, to find out the impact of different factors on overall survival of breast cancer patients coming from Northern Pakistan.
MATERIALS AND METHODS: This observational retrospective study was carried out in the Oncology Department of NORI Hospital. A total of 2,666 patients were included. Data were entered into SPSS 20. Multinomial logistic regression analysis was performed to determine associations of different variables with overall survival. P values <0.05 were considered significant.
RESULTS: The mean age of the patients was 47.6 years, 49.5% being postmenopausal. Some 1,708 were ER positive and 1,615 were PR positive, while Her 2 neu oncogene positivity was found in 683. A total of 1,237 presented with skin involvement and 426 had chest wall involvement. Some 1,663 had > 5cm tumors. Lymph node involvement was detected in 2,131. Overall survival was less than 5 years in 669 patients, only 324 surviving for more than 10 years, and in the remainder overall survival was in the range of 5-10 years.
CONCLUSIONS: Tumor size, lymph node metastases, receptor status, her 2 neu positivity, skin involvement, and chest wall involvement have significant effects whereas age and menopausal status have no significant effect on overall survival of breast cancer patients in Pakistan.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25735323     DOI: 10.7314/apjcp.2015.16.3.1019

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  10 in total

Review 1.  Metastatic and triple-negative breast cancer: challenges and treatment options.

Authors:  Sumayah Al-Mahmood; Justin Sapiezynski; Olga B Garbuzenko; Tamara Minko
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

2.  Estrogen and Progesterone Receptor Expression in Breast Carcinoma and Its Association With Clinicopathological Variables Among the Pakistani Population.

Authors:  Shahzada K Sohail; Rahat Sarfraz; Muhammad Imran; Muhammad Kamran; Samina Qamar
Journal:  Cureus       Date:  2020-08-14

3.  Tamoxifen suppresses brain metastasis of estrogen receptor-deficient breast cancer by skewing microglia polarization and enhancing their immune functions.

Authors:  Shih-Ying Wu; Sambad Sharma; Kerui Wu; Abhishek Tyagi; Dan Zhao; Ravindra Pramod Deshpande; Kounosuke Watabe
Journal:  Breast Cancer Res       Date:  2021-03-18       Impact factor: 6.466

4.  High Moesin Expression Is a Predictor of Poor Prognosis of Breast Cancer: Evidence From a Systematic Review With Meta-Analysis.

Authors:  Xiaoli Hu; Yang Liu; Zhitong Bing; Qian Ye; Chengcheng Li
Journal:  Front Oncol       Date:  2021-11-26       Impact factor: 6.244

5.  The expression and biological function of the PHF2 gene in breast cancer.

Authors:  Lu Zhang; Tian-Li Hui; Yu-Xian Wei; Zhu-Min Cao; Fan Feng; Guo-Sheng Ren; Fan Li
Journal:  RSC Adv       Date:  2018-11-27       Impact factor: 4.036

6.  Effects of core needle biopsy and subsequent neoadjuvant chemotherapy on molecular alterations and outcome in breast cancer.

Authors:  Lingmin Xie; Xiaolei Li; Qinchuan Wang; Jichun Zhou; Jun Shen; Lixi Luo; Yi Lu; Linbo Wang
Journal:  Onco Targets Ther       Date:  2018-02-01       Impact factor: 4.147

7.  US-guided Diffuse Optical Tomography: Clinicopathological Features Affect Total Hemoglobin Concentration in Breast Cancer.

Authors:  Wenxiang Zhi; Yu Wang; Cai Chang; Fen Wang; Yaling Chen; Na Hu; Xiaoli Zhu; Li Xie
Journal:  Transl Oncol       Date:  2018-05-09       Impact factor: 4.243

8.  Survival Rate and Prognostic Factors among Iranian Breast Cancer Patients.

Authors:  Mojtaba Meshkat; Ahmad Reza Baghestani; Farid Zayeri; Maryam Khayamzadeh; Mohammad Esmaeil Akbari
Journal:  Iran J Public Health       Date:  2020-02       Impact factor: 1.429

9.  Frequency and Association Of GSTM1 and GSTT1 Gene Polymorphisms with Survival in Breast Cancer Patients.

Authors:  Phakarat Tangkhuenkhan; Kitiphong Harncharoen; Somchai Thanasitthichai; Danai Tiwawech; Wichai Purisa; Pensri Saelee; Ruxjinda Wattanalai
Journal:  Asian Pac J Cancer Prev       Date:  2020-08-01

10.  Interrelationships Between Ki67, HER2/neu, p53, ER, and PR Status and Their Associations With Tumor Grade and Lymph Node Involvement in Breast Carcinoma Subtypes: Retrospective-Observational Analytical Study.

Authors:  Taghipour Zahir Shokouh; Aalipour Ezatollah; Poorya Barand
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.